SouthErn China REgisTry for Stroke on Traditional Chinese Medicine

Last updated: March 7, 2018
Sponsor: Yefeng Cai
Overall Status: Active - Recruiting

Phase

N/A

Condition

Stroke

Cerebral Ischemia

Brain Injury

Treatment

N/A

Clinical Study ID

NCT03380481
201604020003
  • Ages > 18
  • All Genders

Study Summary

Stroke is the first most common cause of death in China and one of the major causes of functional disability in the adult population.The burden of stoke is significantly increased in China in recent years.

In order to investigate the prognosis of stroke, with diagnostic and treatment information of traditional Chinese medicine (TCM), and assess the effectiveness and safety of TCM for stroke in southern China, the investigators will conduct this multicenter prospective registry study in southern China. This study will recruit 10,000 consecutive eligible patients with acute stroke from more than 50 hospitals. 24 months follow-up will be carried out on-site in hospitals and by telephone to track endpoint (including all-cause mortality, composite cerebrovascular and cardiovascular events at one and two year follow up, and neurological and functional assessments).

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. ≥18 years.

  2. Patients within 14 days of onset of acute stroke (including acute cerebral infarction,transient ischemic attack, acute cerebral hemorrhage, acute subarachnoid hemorrhage).

  3. The patient and/or guardian agree to participate in this study.

Exclusion

Exclusion Criteria:

  1. Patients with silent cerebrovascular disease.

  2. Patients with non-cerebrovascular disease events.

Study Design

Total Participants: 10000
Study Start date:
January 15, 2018
Estimated Completion Date:
December 31, 2020

Connect with a study center

  • Wuyi Traditional Chinese Medicine Hospital of Jiangmen

    Jiangmen, Guangdong 529000
    China

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.